54 research outputs found
ΠΠ΅ΡΡΠ½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Ρ Π»ΠΎΠ°Π·ΠΌ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ
Goal. To assess the efficacy and safety of Azelic (15% gel of azelaic acid for topical administration) for the treatment of chloasma in pregnant women. Materials and methods. The study involved 28 pregnant women aged 18-36 (mean age: 24.7) with a normal course of pregnancy. The patients consulted a doctor in the spring, summer or fall complaining of focal skin hyperpigmentation on the face, chin and chest area. Ten patients (35.7%) developed hyperpigmentation prior to their pregnancy and 18 women (64.3%) - during the pregnancy. As of the consultation date, the pregnancy terms in all of the patients were 18-20 weeks. Chloasma was diagnosed by using dermatoscopy and skin examination with the Woodβs lamp. The patients were informed about the content and procedure of the study and gave their consent to take part in the study. Thin layers of Azelic (15% gel of azelaic acid for topical administration) were applied to the hyperpigmented skin of the patients and gently rubbed twice a day (in the morning and evening) as topical treatment for four months. The treatment results were assessed taking into consideration the patientβs subjective assessment, study group structure depending on the clinical efficacy, percentage of adverse events, and survey results based on the Dermatology Life Quality Index questionnaire. To reveal any potential general toxicological effects of the treatment, hepatic samples, total blood count and coagulogram results were analyzed as a part of obstetrical and gynecologic care for pregnant women. Key findings. Positive dynamics of the following characteristics was revealed: subjective assessment of treatment results by the patients, clinical efficacy of treatment and life quality index. Therapeutic results were observed as early as after one month but not later than three months after the treatment began. The therapeutic efficacy was recorded in 92.9-96.4% of all cases after four months of treatment: pigment spots disappeared or became paler, and their dimensions and their contrast as compared to the healthy skin reduced, the skin texture and life quality improved (the Dermatology Life Quality Index reduced from 15.5 Β± 1.8 to 6.7 Β± 0.5 points against the background of the treatment efficacy: from severe to moderate impact of the disease on the patientβs life, respectively). Five women (17.9%) developed erythema and burning sensations in the drug application site within the first two weeks immediately after the gel application (one of the patients had the same symptoms for six weeks of the treatment); the symptoms were weak and transient and did not require any additional treatment. Hepatic samples, total blood count and coagulogram results were within physiological standards during the treatment. Conclusion. Topical application of Azelic (15% gel of azelaic acid for topical administration) twice a day for four months is an efficient and safe method to treat chloasma in pregnant women.Π¦Π΅Π»Ρ. ΠΡΠ΅Π½ΠΈΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΡ ΠΠ·Π΅Π»ΠΈΠΊΠ° (15% Π³Π΅Π»Ρ Π°Π·Π΅Π»Π°ΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ) ΠΏΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Ρ
Π»ΠΎΠ°Π·ΠΌΡ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΎΠ΄ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ΠΌ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΈΡΡ 28 ΠΆΠ΅Π½ΡΠΈΠ½ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 18-36 Π»Π΅Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ 24,7 Π³ΠΎΠ΄Π°) Ρ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎ ΠΏΡΠΎΡΠ΅ΠΊΠ°ΡΡΠ΅ΠΉ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΡΡ. ΠΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ ΠΎΠ±ΡΠ°ΡΠΈΠ»ΠΈΡΡ ΠΊ Π²ΡΠ°ΡΡ Π² Π²Π΅ΡΠ΅Π½Π½Π΅-Π»Π΅ΡΠ½Π΅-ΠΎΡΠ΅Π½Π½ΠΈΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π³ΠΎΠ΄Π° Ρ ΠΆΠ°Π»ΠΎΠ±Π°ΠΌΠΈ Π½Π° ΠΎΡΠ°Π³ΠΎΠ²ΡΠ΅ Π³ΠΈΠΏΠ΅ΡΠΏΠΈΠ³ΠΌΠ΅Π½ΡΠ°ΡΠΈΠΈ Π½Π° ΠΊΠΎΠΆΠ΅ Π»ΠΈΡΠ°, ΠΏΠΎΠ΄Π±ΠΎΡΠΎΠ΄ΠΊΠ° ΠΈ Π² ΠΎΠ±Π»Π°ΡΡΠΈ Π΄Π΅ΠΊΠΎΠ»ΡΡΠ΅. ΠΠΈΠΏΠ΅ΡΠΏΠΈΠ³ΠΌΠ΅Π½ΡΠ°ΡΠΈΠΈ ΠΏΠΎΡΠ²ΠΈΠ»ΠΈΡΡ Ρ 10 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ (35,7%) Π΄ΠΎ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ; Ρ 18 ΠΆΠ΅Π½ΡΠΈΠ½ (64,3%) - Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ. ΠΠ° ΠΌΠΎΠΌΠ΅Π½Ρ ΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ ΡΡΠΎΠΊΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ Ρ Π²ΡΠ΅Ρ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Π±ΡΠ»ΠΈ 18-20 Π½Π΅Π΄Π΅Π»Ρ. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π΄Π΅ΡΠΌΠ°ΡΠΎΡΠΊΠΎΠΏΠΈΠΈ ΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠΆΠΈ ΠΏΠΎΠ΄ Π»Π°ΠΌΠΏΠΎΠΉ ΠΡΠ΄Π° ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ Π΄ΠΈΠ°Π³Π½ΠΎΠ·: Ρ
Π»ΠΎΠ°Π·ΠΌΠ°. ΠΡΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ Π±ΡΠ»ΠΈ ΠΎΡΠ²Π΅Π΄ΠΎΠΌΠ»Π΅Π½Ρ ΠΎ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠΈ ΠΈ ΠΏΠΎΡΡΠ΄ΠΊΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΈ Π΄Π°Π»ΠΈ Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΠ½ΠΎΠ΅ ΡΠΎΠ³Π»Π°ΡΠΈΠ΅ Π½Π° ΡΡΠ°ΡΡΠΈΠ΅ Π² Π½Π΅ΠΌ. ΠΠ»Ρ ΠΌΠ΅ΡΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ Π²ΡΠ΅ΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠ°ΠΌ 2 ΡΠ°Π·Π° Π² ΡΡΡΠΊΠΈ (ΡΡΡΠΎΠΌ ΠΈ Π²Π΅ΡΠ΅ΡΠΎΠΌ) Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 4 ΠΌΠ΅Ρ. Π½Π° Π³ΠΈΠΏΠ΅ΡΠΏΠΈΠ³ΠΌΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΡΠ°ΡΡΠΊΠΈ ΠΊΠΎΠΆΠΈ ΡΠΎΠ½ΠΊΠΈΠΌ ΡΠ»ΠΎΠ΅ΠΌ Π½Π°Π½ΠΎΡΠΈΠ»ΠΈ ΠΈ ΡΠ»Π΅Π³ΠΊΠ° Π²ΡΠΈΡΠ°Π»ΠΈ 15% Π³Π΅Π»Ρ Π°Π·Π΅Π»Π°ΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ (ΠΠ·Π΅Π»ΠΈΠΊ). Π Π΅Π·ΡΠ»ΡΡΠ°Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ Ρ ΡΡΠ΅ΡΠΎΠΌ ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠ°ΠΌΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ, ΡΡΡΡΠΊΡΡΡΡ ΠΈΡΡΠ»Π΅Π΄ΡΠ΅ΠΌΠΎΠΉ Π³ΡΡΠΏΠΏΡ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, ΠΏΡΠΎΡΠ΅Π½ΡΠ° ΡΠ»ΡΡΠ°Π΅Π² Π½Π΅ΠΆΠ΅Π»Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ²Π»Π΅Π½ΠΈΠΉ, ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π°Π½ΠΊΠ΅ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎ ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΡ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΠ½Π΄Π΅ΠΊΡΠ° ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ. ΠΠ»Ρ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΡ
ΠΎΠ±ΡΠ΅ΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΡΠ΅ΠΊΡΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ Π°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π»ΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ½ΡΡ
ΠΏΡΠΎΠ±, ΠΎΠ±ΡΠ΅Π³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΊΡΠΎΠ²ΠΈ, ΠΊΠΎΠ°Π³ΡΠ»ΠΎΠ³ΡΠ°ΠΌΠΌΡ, ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠΌΡΡ
Π² ΡΠ°ΠΌΠΊΠ°Ρ
Π°ΠΊΡΡΠ΅ΡΡΠΊΠΎ-Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π΅Π½ΠΈΡ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ. ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΡΠ²Π»Π΅Π½Π° ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ° ΡΠ»Π΅Π΄ΡΡΡΠΈΡ
Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊ: ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠ°ΠΌΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ. ΠΡΡΠ΅ΠΊΡ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΡΠ» ΠΎΡΠΌΠ΅ΡΠ΅Π½ ΡΠΆΠ΅ ΡΠ΅ΡΠ΅Π· 1 ΠΌΠ΅Ρ. ΠΈ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎ - ΡΠ΅ΡΠ΅Π· 3 ΠΌΠ΅Ρ. ΠΏΠΎΡΠ»Π΅ Π½Π°ΡΠ°Π»Π° Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΠ° 4 ΠΌΠ΅Ρ. Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π·Π°ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π½Π° Π² 92,9-96,4% ΡΠ»ΡΡΠ°Π΅Π²: ΠΏΠΈΠ³ΠΌΠ΅Π½ΡΠ½ΡΠ΅ ΠΏΡΡΠ½Π° ΠΈΡΡΠ΅Π·Π°Π»ΠΈ, Π±Π»Π΅Π΄Π½Π΅Π»ΠΈ, ΡΠΌΠ΅Π½ΡΡΠ°Π»ΠΈΡΡ Π² ΡΠ°Π·ΠΌΠ΅ΡΠ΅ ΠΈ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠ½ΠΎΡΡΠΈ ΡΠΎ Π·Π΄ΠΎΡΠΎΠ²ΠΎΠΉ ΠΊΠΎΠΆΠ΅ΠΉ, Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π»Π°ΡΡ ΡΠ΅ΠΊΡΡΡΡΠ° ΠΊΠΎΠΆΠΈ; ΡΠ»ΡΡΡΠ°Π»ΠΎΡΡ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ (ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΠ½Π΄Π΅ΠΊΡΠ° ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ ΠΏΡΠΈ Π½Π°Π»ΠΈΡΠΈΠΈ ΡΡΡΠ΅ΠΊΡΠ° Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠΌΠ΅Π½ΡΡΠΈΠ»ΡΡ Ρ 15,5 Β± 1,8 Π±Π°Π»Π»Π° Π΄ΠΎ 6,7 Β± 0,5 Π±Π°Π»Π»Π°: Ρ ΡΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΎ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠ³ΠΎ Π²Π»ΠΈΡΠ½ΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π½Π° ΠΆΠΈΠ·Π½Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ). Π£ 5 ΠΆΠ΅Π½ΡΠΈΠ½ (17,9%) Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠ΅ΡΠ²ΡΡ
2 Π½Π΅Π΄Π΅Π»Ρ Π½Π΅ΠΏΠΎΡΡΠ΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎ ΠΏΠΎΡΠ»Π΅ Π½Π°Π½Π΅ΡΠ΅Π½ΠΈΡ Π³Π΅Π»Ρ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈΡΡ ΡΡΠΈΡΠ΅ΠΌΠ° ΠΈ ΠΆΠΆΠ΅Π½ΠΈΠ΅ Π² ΠΎΠ±Π»Π°ΡΡΠΈ Π½Π°Π½Π΅ΡΠ΅Π½ΠΈΡ ΡΡΠ΅Π΄ΡΡΠ²Π° (Ρ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· Π½ΠΈΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΡ ΠΏΡΠΎΡΠ²Π»ΡΠ»ΠΈΡΡ Π΄ΠΎ 6-ΠΉ Π½Π΅Π΄Π΅Π»ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ), Π½ΠΎΡΠΈΠ»ΠΈ Π½Π΅Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΉ ΠΏΡΠΎΡ
ΠΎΠ΄ΡΡΠΈΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ, Π½Π΅ ΡΡΠ΅Π±ΠΎΠ²Π°Π»ΠΈ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ. ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ½ΡΡ
ΠΏΡΠΎΠ±, ΠΎΠ±ΡΠ΅Π³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΊΡΠΎΠ²ΠΈ, ΠΊΠΎΠ°Π³ΡΠ»ΠΎΠ³ΡΠ°ΠΌΠΌΡ Π² Ρ
ΠΎΠ΄Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½ΠΎΡΠΌΡ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ΅ΡΡΠ½ΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΠ·Π΅Π»ΠΈΠΊΠ° (15% Π³Π΅Π»Ρ Π°Π·Π΅Π»Π°ΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ Π΄Π»Ρ Π½Π°ΡΡΠΆΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ) 2 ΡΠ°Π·Π° Π² Π΄Π΅Π½Ρ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 4 ΠΌΠ΅Ρ. ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π»Π΅ΡΠ΅Π½ΠΈΡ Ρ
Π»ΠΎΠ°Π·ΠΌΡ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ
Microcirculatory Status and Metabolic Activity of Tissues after Local Administration of Autologous Plasma on the Model of Explosive Soft Tissue Wound in Rats
Background. The possibility of local application of autologous blood plasma (ABP) in soft tissue injuries is currently of particular interest.Objectives. Evaluation of the effects of peri-wound (perifocal) administration of ABP on red blood parameters, microcirculation and oxygen supply of soft tissues of the limb in experimental explosive wound (EW) in rats.Methods. EW was simulated on male Wistar rats (n=146) using a firecracker with a pyrotechnic mixture (patent RU No. 2741238 dated 22.01.2021). Animals were divided into 4 groups: control (2), comparison (1), main (1). The volume of blood loss in explosive wounds was 8 and 15% of the estimated circulating blood volume (CBV) of the animal. Blood was drawn from the rat tail to obtain ABP. 3 hours after the injury, ABP or 0.9% sodium chloride solution was injected intramuscularly into the explosive wound area at a rate of 2.0 ml/kg of animal weight. After 3, 7, 14, 28 days, the number of red blood cells, haemoglobin content, haematocrit were determined in the blood, and microcirculation and oxidative metabolism parameters were determined in the skeletal muscles of the injured area. The data were processed using Microsoft Excel 2013 (Microsoft, USA) and Statistica 10.0 (StatSoft Inc., USA).Results. Blood loss of 8% of the CBV in injured animals did not lead to changes in the quantitative composition of peripheral red blood. After an explosive wound with a blood loss of 15% of the CBV, there was a moderate decrease in the number of red blood cells (from 8.3Γ1012/l to 6.5Γ1012/l, p < 0.02), haemoglobin level (from 149.5 g/l to 118 g/l, p < 0.01), haematocrit (from 43.8% to 33.6%, p < 0.01) with recovery by day 7 of observation. The explosive soft tissue wound was characterized by marked post-traumatic microcirculatory disorders irrespective of the amount of blood loss. Perifocal intramuscular administration of ABP in animals with an explosive wound and blood loss of 15% CBV reduced the severity of post-traumatic microcirculatory and oxidative metabolic disorders mainly in the early post-traumatic period, as evidenced by an increase in the perfusion variation coefficient Kv by 1.2β1.3 times (p < 0.05), tissue oxygen consumption U by 20β22% (p < 0.05) and fluorescent oxygen consumption by FPC by 48% (p < 0.05).Conclusion. With an experimental explosive wound of the soft tissues of the thigh in rats, a single early (3 hours after the injury) peri-wound intramuscular administration of ABP reduces the severity of local post-traumatic microcirculatory and metabolic disorders in skeletal muscle
ΠΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ ΠΏΡΠΈ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΠΎΠ½ΠΈΠΈ
The aim of the study was to study the physical and psychological components regarding the quality of lifeΒ of patients with cervical dystonia.Material and methods. 170 respondents were examined. The main group included 120 patients withΒ cervical dystonia, 50 patients were included in the control group, consisting of patients with cervicalgiaΒ of various genesis. The diagnosis of cervical dystonia met uniform criteria for the diagnosis and treatmentΒ of dystonia adopted in 2011 by the European Federation of Neurological Societies and the MovementΒ Disorders Society (European Federation of Neurological Societies / Movement Disorders Society, EFNS /Β MDS). In the control group, the pain syndrome of the cervical spine was caused by a degenerative processΒ and was confirmed by X-ray examination and /or MRI. As part of our research, we determined the qualityΒ of life in men and women in both groups using the SF-36 questionnaire with a study of the parameters ofΒ physical and psychological well-being.Results and conclusion. A considerably significant effect of cervical dystonia on the somatic and mentalΒ parameters regarding the quality of life in both men and women has been established. SignificantΒ decrease in all indicators representing the quality of life in patients with cervical dystonia was revealedΒ compared with respondents without dystonic hyperkinesis. As a chronic disease, cervical dystonia leads toΒ psycho-physiological stress, which significantly impairs the quality of life of patients. Significant genderΒ differences were identified: women from the groups of cervical dystonia and cervicalgia were more oftenΒ exposed to psychological deprivation and reduced physical activity than men from the same groups.Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠΈΡΡ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠΎΡΡΠ°Π²Π»ΡΡΡΠΈΠ΅ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
, ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
Β ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΠΎΠ½ΠΈΠ΅ΠΉ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ 170 ΡΠ΅ΡΠΏΠΎΠ½Π΄Π΅Π½ΡΠΎΠ²: 120 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΠΎΠ½ΠΈΠ΅ΠΉΒ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ, 50 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ Π² Π³ΡΡΠΏΠΏΡ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ β ΡΠ΅ΡΠΏΠΎΠ½Π΄Π΅Π½ΡΡ Ρ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»Π³ΠΈΡΠΌΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½Π΅Π·Π°. ΠΠΈΠ°Π³Π½ΠΎΠ· ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΠΎΠ½ΠΈΠΈ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈ, ΡΠΎΠ³Π»Π°ΡΠ½ΠΎ Π΅Π΄ΠΈΠ½ΡΠΌΒ ΠΊΡΠΈΡΠ΅ΡΠΈΡΠΌ ΠΏΠΎ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π΄ΠΈΡΡΠΎΠ½ΠΈΠΈ, ΠΏΡΠΈΠ½ΡΡΡΠΌ Π² 2011 Π³. ΠΠ²ΡΠΎΠΏΠ΅ΠΉΡΠΊΠΎΠΉ ΡΠ΅Π΄Π΅ΡΠ°ΡΠΈΠ΅ΠΉ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠ±ΡΠ΅ΡΡΠ² ΠΈ ΠΠ±ΡΠ΅ΡΡΠ²ΠΎΠΌ Π΄Π²ΠΈΠ³Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ² (European Federation of NeurologicalΒ Societies / Movement Disorders Society, EFNS / MDS). ΠΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ Π² ΡΠ΅ΠΉΠ½ΠΎΠΌ ΠΎΡΠ΄Π΅Π»Π΅ ΠΏΠΎΠ·Π²ΠΎΠ½ΠΎΡΠ½ΠΈΠΊΠ° Ρ Π³ΡΡΠΏΠΏΡ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π±ΡΠ» Π²ΡΠ·Π²Π°Π½ Π΄Π΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠ²Π½ΡΠΌ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠΌ ΠΈ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ ΡΠ΅Π½ΡΠ³Π΅Π½ΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌΒ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈ (ΠΈΠ»ΠΈ) ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠ΅ΠΉ. Π ΡΠ°ΠΌΠΊΠ°Ρ
ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΠ³ΠΎ Π½Π°ΠΌΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΎΡΡ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ Ρ ΠΌΡΠΆΡΠΈΠ½ ΠΈ ΠΆΠ΅Π½ΡΠΈΠ½ Π² ΠΎΠ±Π΅ΠΈΡ
Π³ΡΡΠΏΠΏΠ°Ρ
Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠ° SF-36Β Ρ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΎΠ² ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π±Π»Π°Π³ΠΎΠΏΠΎΠ»ΡΡΠΈΡ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ Π·Π°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π·Π½Π°ΡΠΈΠΌΠΎΠ΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΠΎΠ½ΠΈΠΈ Π½Π°Β ΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΏΡΠΈΡ
ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ ΠΊΠ°ΠΊ Ρ ΠΌΡΠΆΡΠΈΠ½, ΡΠ°ΠΊ ΠΈ Ρ ΠΆΠ΅Π½ΡΠΈΠ½. ΠΡΡΠ²Π»Π΅Π½ΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π²ΡΠ΅Ρ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΠΎΠ½ΠΈΠ΅ΠΉΒ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΡΠ΅ΡΠΏΠΎΠ½Π΄Π΅Π½ΡΠ°ΠΌΠΈ, Π½Π΅ ΠΈΠΌΠ΅ΡΡΠΈΡ
Π΄ΠΈΡΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π³ΠΈΠΏΠ΅ΡΠΊΠΈΠ½Π΅Π·Π°. Π¦Π΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΡΡΠΎΠ½ΠΈΡΒ ΠΊΠ°ΠΊ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΠΏΡΠΈΡ
ΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌΡ Π½Π°ΠΏΡΡΠΆΠ΅Π½ΠΈΡ, ΡΡΠΎ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΒ ΡΡ
ΡΠ΄ΡΠ°Π΅Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
. ΠΡΡΠ²Π»Π΅Π½Ρ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΠ΅ Π³Π΅Π½Π΄Π΅ΡΠ½ΡΠ΅ Π²Π½ΡΡΡΠΈΠ³ΡΡΠΏΠΏΠΎΠ²ΡΠ΅ ΡΠ°Π·Π»ΠΈΡΠΈΡ:Β ΠΆΠ΅Π½ΡΠΈΠ½Ρ ΠΈΠ· Π³ΡΡΠΏΠΏ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΡΠΎΠ½ΠΈΠΈ ΠΈ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»Π³ΠΈΠΉ Π² Π±ΠΎΠ»ΡΡΠ΅ΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΏΠΎΠ΄Π²Π΅ΡΠΆΠ΅Π½Ρ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄Π΅ΠΏΡΠΈΠ²Π°ΡΠΈΠΈ ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ, ΡΠ΅ΠΌ ΠΌΡΠΆΡΠΈΠ½Ρ ΠΈΠ· ΡΡΠΈΡ
ΠΆΠ΅ Π³ΡΡΠΏΠΏ
The efficiency of replenishment of acute blood loss by an experimental blood substitute comprising humanβs umbilical cord blood red blood cells
Π’ΠΎ assess the effectiveness of the experimental blood substitute containing erythrocytes of human umbilical cord blood, were analyzed the dynamics of indicators of cardiovascular and respiratory systems, quantitative indicators of red blood, the severity of hemolysis in dogs within 24 hours after equivalent replenishment of acute blood loss for about 50% of the volume of circulating blood. The comparative drug was the adult human packed RBCs, used in clinical practice. It was found that after replenishment of blood loss in dogs, hemolytic anemia developed less pronounced after transfusion of the blood substitute with erythrocytes of human umbilical cord blood. Indicators of cardiovascular and respiratory systems were restored to the baseline in 24 hours after replenishment of acute blood loss by an experimental blood substitute with human umbilical cord blood erythrocytes with persistent changes after transfusion of the adult human packed RBCs. The relatively higher efficiency of the experimental blood substitute is due to the structural and functional stability of erythrocytes in the umbilical cord blood. A conclusion was made about the prospects of development of blood substitutes-oxygen carriers containing human umbilical cord blood erythrocytes.Π‘ ΡΠ΅Π»ΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΡΠΎΠ²Π΅Π·Π°ΠΌΠ΅Π½ΠΈΡΠ΅Π»Ρ, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠ΅Π³ΠΎ ΡΡΠΈΡΡΠΎΡΠΈΡΡ ΠΏΡΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°, ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ ΠΈ Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌ, ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΊΡΠ°ΡΠ½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ, Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π³Π΅ΠΌΠΎΠ»ΠΈΠ·Π° Ρ ΡΠΎΠ±Π°ΠΊ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 24 ΡΠ°ΡΠΎΠ² ΠΏΠΎΡΠ»Π΅ Π²ΠΎΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΎΡΡΡΠΎΠΉ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΎΠΏΠΎΡΠ΅ΡΠΈ ΠΎΠΊΠΎΠ»ΠΎ 50% ΠΎΡ ΠΎΠ±ΡΠ΅ΠΌΠ° ΡΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠ΅ΠΉ ΠΊΡΠΎΠ²ΠΈ. ΠΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠΌ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΡΠ»ΡΠΆΠΈΠ»Π° ΡΡΠΈΡΡΠΎΡΠΈΡΠ°ΡΠ½Π°Ρ ΠΌΠ°ΡΡΠ° ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°, ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΠ°Ρ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΏΠΎΡΠ»Π΅ Π²ΠΎΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΊΡΠΎΠ²ΠΎΠΏΠΎΡΠ΅ΡΠΈ Ρ ΡΠΎΠ±Π°ΠΊ ΡΠ°Π·Π²ΠΈΠ²Π°Π»Π°ΡΡ Π³Π΅ΠΌΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π°Π½Π΅ΠΌΠΈΡ, ΠΌΠ΅Π½Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½Π°Ρ ΠΏΠΎΡΠ»Π΅ ΡΡΠ°Π½ΡΡΡΠ·ΠΈΠΈ ΠΊΡΠΎΠ²Π΅Π·Π°ΠΌΠ΅Π½ΠΈΡΠ΅Π»Ρ Ρ ΡΡΠΈΡΡΠΎΡΠΈΡΠ°ΠΌΠΈ ΠΏΡΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ ΠΈ Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌ Π²ΠΎΡΡΡΠ°Π½Π°Π²Π»ΠΈΠ²Π°Π»ΠΈΡΡ Π΄ΠΎ ΠΈΡΡ
ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΡΡΠΎΠ²Π½Ρ ΡΠ΅ΡΠ΅Π· 24 ΡΠ°ΡΠ° ΠΏΠΎΡΠ»Π΅ Π²ΠΎΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΊΡΠΎΠ²ΠΎΠΏΠΎΡΠ΅ΡΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠΌ ΠΊΡΠΎΠ²Π΅Π·Π°ΠΌΠ΅Π½ΠΈΡΠ΅Π»Π΅ΠΌ Ρ ΡΡΠΈΡΡΠΎΡΠΈΡΠ°ΠΌΠΈ ΠΏΡΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΏΡΠΈ ΡΠΎΡ
ΡΠ°Π½ΡΡΡΠΈΡ
ΡΡ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡΡ
ΠΏΠΎΡΠ»Π΅ Π²Π»ΠΈΠ²Π°Π½ΠΈΡ ΡΡΠΈΡΡΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠ°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΡΠΎΠ²Π΅Π·Π°ΠΌΠ΅Π½ΠΈΡΠ΅Π»Ρ ΠΎΠ±ΡΡΡΠ½ΡΠ΅ΡΡΡ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΡΡ ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ² ΠΏΡΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ. Π‘Π΄Π΅Π»Π°Π½ΠΎ Π·Π°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΎ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²Π΅Π·Π°ΠΌΠ΅Π½ΠΈΡΠ΅Π»Π΅ΠΉ-ΠΏΠ΅ΡΠ΅Π½ΠΎΡΡΠΈΠΊΠΎΠ² ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π°, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ
ΡΡΠΈΡΡΠΎΡΠΈΡΡ ΠΏΡΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
Π’ΠΎ the question about the requirements of translation of medical organizations on a strict anti-epidemic regime
The paper presents an overview of the legislative and regulatory framework, on the basis of which is the translation of multidisciplinary healthcare organizations on a strict anti-epidemic mode. Reviewed the list of guidance documents that are working in medical organizations in identifying patients (corpses) infectious diseases, which are categorized vysokochastotnykh, particularly hazardous and quarantine infections.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΎΠ±Π·ΠΎΡ Π·Π°ΠΊΠΎΠ½ΠΎΠ΄Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΈ Π½ΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΠΎΠΉ Π±Π°Π·Ρ, Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΊΠΎΡΠΎΡΠΎΠΉ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡΡ ΠΏΠ΅ΡΠ΅Π²ΠΎΠ΄ ΠΌΠ½ΠΎΠ³ΠΎΠΏΡΠΎΡΠΈΠ»ΡΠ½ΡΡ
ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ Π½Π° ΡΡΡΠΎΠ³ΠΈΠΉ ΠΏΡΠΎΡΠΈΠ²ΠΎΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ΅ΠΆΠΈΠΌ ΡΠ°Π±ΠΎΡΡ. Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½ ΠΏΠ΅ΡΠ΅ΡΠ΅Π½Ρ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠΈΡ
Π΄ΠΎΠΊΡΠΌΠ΅Π½ΡΠΎΠ², ΠΎΡΡΠ°Π±Π°ΡΡΠ²Π°Π΅ΠΌΡΡ
Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡΡ
ΠΏΡΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
(ΡΡΡΠΏΠΎΠ²) ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΊ ΠΊΠ°ΡΠ΅Π³ΠΎΡΠΈΠΈ Π²ΡΡΠΎΠΊΠΎΠΊΠ°Π½ΡΠ°Π³ΠΈΠΎΠ·Π½ΡΡ
, ΠΎΡΠΎΠ±ΠΎ ΠΎΠΏΠ°ΡΠ½ΡΡ
ΠΈ ΠΊΠ°ΡΠ°Π½ΡΠΈΠ½Π½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ
Vitamin D (steroid hormone) and the nervous system diseases (literature review)
The present review aims to summarize the activities of vitamin D effects on the nervous system and to clarify a vitamin D role in brain diseases, in the pathogenesis or as a serum biomarker for the disease development and severity. Objective: correlation between chronic nervous system diseases and vitamin D level. Methods: a literature research in PubMed and in Russian electronic resources by keywords: vitamin D, brain diseases, chronic nervous system diseases. Results. Vitamin D as a neurosteroid hormone stimulates cerebral activity in both adult and embryonic brain regulates the activity of neural circuits which are responsible for locomotor, reward-dependent and emotional behavior. Patients with autism spectrum disorders, schizophrenia, Alzheimer disease, multiple sclerosis, Parkinson disease and sleep disorders have been shown to have low level of vitamin D. Discussion. Data are controversial, a further study of vitamin D hypovitaminosis significance is essential for the nervous system chronic diseases manifestation and evaluation of the vitamin D dietary supplement efficiency in patients with the nervous system pathology
- β¦